NDC 67877-0259-30
Rasagiline .5 mg/1 TABLET
Available — 2-Day Shipping
NDC
67877-0259-30
Generic Name
Rasagiline
Brand Name
Rasagiline
Strength
.5 mg/1
Dosage Form
TABLET
Route
ORAL
Package Size
—
Labeler
Ascend Laboratories, LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD). Rasagiline tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson’s disease ( 1 )
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Rasagiline Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Rasagiline NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 67877-0259-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).